Bono, J. S. D., Mehra, N., Tang, M., Wang, S., Jafari, F., Imai, K., Efstathiou, E. (2026). IDeate-Prostate02: A phase 1/2, open-label umbrella substudy of ifinatamab deruxtecan-based treatment combinations or as monotherapy in participants with previously treated metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps297